Effects of synthetic angiotensin II on catecholamine levels and biological activity.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D004285:Dogs; D004837:Epinephrine / Q000378:metabolism; D007668:Kidney / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010227:Parabiosis; D010477:Perfusion; D011817:Rabbits; D051381:Rats; D013564:Sympathetic Nervous System / Q000502:physiology; D014439:Tyramine / Q000494:pharmacology; D014556:Urine
D002395:Catecholamines; D000804:Angiotensin II; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine